Cytosorbents
CTSO
#10845
Rank
NZ$25.82 M
Marketcap
NZ$8.20
Share price
-7.39%
Change (1 day)
605.54%
Change (1 year)

Market capitalization of Cytosorbents (CTSO)

Market cap: NZ$25.82 Million

As of November 2026 Cytosorbents has a market cap of NZ$25.82 Million. This makes Cytosorbents the world's 10845th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cytosorbents from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$25.82 M-64.97%
2025NZ$73.74 M-19.48%
2024NZ$91.58 M0.01%
2023NZ$91.57 M-14.04%
2022NZ$0.10 B-60.06%
2021NZ$0.26 B-44.14%
2020NZ$0.47 B156.06%
2019NZ$0.18 B-51.29%
2018NZ$0.38 B45.76%
2017NZ$0.26 B31.04%
2016NZ$0.20 B-3.05%
2015NZ$0.20 B-30.16%
2014NZ$0.29 B674.15%
2013NZ$38.22 M12.53%
2012NZ$33.97 M-6.59%
2011NZ$36.36 M63.15%
2010NZ$22.29 M28.38%
2009NZ$17.36 M398.55%
2008NZ$3.48 M

End of Day market cap according to different sources

On Nov 15th, 2026 the market cap of Cytosorbents was reported to be:

NZ$27.89 Million
by Nasdaq info icon info icon
NZ$27.89 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Boston Scientific
BSX
NZ$115.61 B 447,496.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
NZ$30.84 B 119,302.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO.defunct
NZ$2.70 B 10,376.26%๐Ÿ‡บ๐Ÿ‡ธ USA